Sanofi to Acquire Dynavax, Adding a Marketed Adult Hepatitis B Vaccine and Phase 1/2 Shingles Candidate to the Pipeline ...Middle East

Dynavax stockholders to receive $15.50 in cash, a 39% premium to Dynavax closing share price on December 23, 2025 EMERYVILLE, Calif., Dec. 24, 2025 /PRNewswire/ -- Sanofi announced today that it has entered into an agreement to acquire Dynavax Technologies Corporation (Nasdaq: DVAX), a...

Hence then, the article about sanofi to acquire dynavax adding a marketed adult hepatitis b vaccine and phase 1 2 shingles candidate to the pipeline was published today ( Wednesday 24/12/2025 - 09:29 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Sanofi to Acquire Dynavax, Adding a Marketed Adult Hepatitis B Vaccine and Phase 1/2 Shingles Candidate to the Pipeline )

Also on site :

• Nona Biosciences Expands Integrated Discovery-to-Clinical Capabilities Through Strategic Platform Growth
• Golfer Masashi ‘Jumbo’ Ozaki dies at 78
• Russell Brand Prays on Instagram After New Charges of Rape and Sexual Assault